Immunochemistry and immunology devices and systems play a crucial role in the diagnosis and monitoring of disease. With the help of immune assay systems, doctors and medical professionals can obtain precise and reliable test results. These tests are particularly important for the early detection of diseases such as cancer.
Immune assay systems are based on immunochemical reactions in which antibodies and antigens interact with each other. These tests can be performed in various formats, including ELISA (enzyme-linked immunosorbent assay), immunoblotting and immunofluorescence. They allow the measurement of biomarkers in blood, urine or other body fluids to provide clues to the presence of disease.
The development of rapid diagnostic tests has revolutionised medical diagnostics. These tests provide results within minutes and enable rapid decision-making in the treatment of patients. They are easy to perform and do not require expensive laboratory equipment. Rapid diagnostic tests are particularly useful in regions with limited access to medical care or in acute emergency situations.
In cancer diagnosis, tests to detect specific tumour markers are of great importance. By analysing blood samples, these tests can provide clues to the presence of cancer and help doctors decide on further diagnostic measures. Advances in immunology have led to the development of highly sensitive tests for cancer diagnosis that allow early detection and better prognosis.
Immunochemistry and immunology equipment and systems are constantly evolving to improve the accuracy, reliability and efficiency of diagnosis. Automated systems facilitate workflow and reduce human error. In addition, modern instruments allow multiple tests to be performed simultaneously, saving time and resources.
The importance of immunochemistry and immunology devices and systems in medical diagnostics cannot be overestimated. They play a crucial role in the early detection of diseases and enable timely treatment. Continued research and development in this field promises further advances and innovations in diagnostic technology that have the potential to improve healthcare worldwide.
VISIA LAB is an emerging company engaged in the design, development and production of hardware and software solutions for IVD clinical laboratory diagnostics, with various fields of application,
Vitassay Healthcare Vitassay tests focus on three major families: Vitassay Rapid Test Vitassay qPCR Vitassay Turbidimetry We develop and market clinical diagnostic tests for the early detection of
50 years as a market leading medical manufacturer - and still counting... The state of excellence in R&D, product portfolio and reliable sales and delivery which customers and partners
Vitrosens Biotechnology, based in Turkey, is a leading diagnostics firm with expertise in in-vitro-diagnostic ( IVD ), molecular biology, and POCT. Operating the largest rapid test facility in Turkey
The manufacturer of ELISA test kits and raw materials: monoclonal antibodies, native and recombinant antigens, TMB solution, conjugates, stabilizers. The Vitrotest ELISA line of reagents incorporate
Werfen is a growing, family-owned, innovative company founded in 1966 in Barcelona, Spain. We are a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics,
The Xema Corporate Group started in February 1993 as the private company Xema Co. Ltd. in Moscow, Russia. Over the course of twenty years, Xema has developed from a small-scalecontract manufacturer
Hanzhou Funworld Biotech Co., LTD was founded in June 2020. Lead by the R & D team which had over 20 years’ experience in IVD fields. Moreover, they are devoted to developing